Loading...
Guest User
Welcome! Please login.
| IPO Listing At | BSE, NSE |
| IPO Issue Type | Book Build Issue |
| Issue Size | ₹920.00 Cr |
| Fresh Issue | ₹770.00 Cr |
| Offer for Sale | ₹150.00 Cr |
| Face Value | ₹2 Per Equity Share |
| Price Band | ₹154.00-162.00 per share |
| BSE Code | 544645 |
| NSE Code | PARKHOSPS |
| Registrar | Kfin Technologies Ltd. |
| Lead Managers | Dam Capital Advisors Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 92 shares and in multiples thereof
Incorporated in 2011, Park Medi World Limited is a private hospital chain operating primarily in North India, with a total bed capacity of 3,000 beds as of March 31, 2025.
The company operates 14 multi-super speciality hospitals under the ‘Park’ brand. All hospitals are accredited by the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and eight are also accredited by the National Accreditation Board for Testing and Calibration Laboratories (NABL). The network includes facilities in Haryana, Delhi, Punjab, and Rajasthan.
Park Hospital offers more than 30 super speciality and speciality services, such as internal medicine, neurology, urology, gastroenterology, general surgery, orthopaedics, and oncology.
As of Sep 30, 2025, the hospitals are equipped with 870 bedded intensive care unit (ICU) beds, 67 operating theatres (OTs), and an oxygen generation plant at each location to support critical care.
It has hospitals across several states including Haryana (Ambala, Gurugram, Karnal, Panipat, Palam Vihar, Sonipat, Faridabad), Delhi, Punjab (Patiala, Mohali), and Rajasthan (Jaipur, Behror).
As of September 30, 2025, Park Medi World Limited had a workforce of 1,014 doctorsa and 2,142 nurses
.Competitive strengths:
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the Company and certain of the Subsidiaries. | 380.00 |
| 2 | Funding capital expenditure for development of new hospital and expansion of existing hospital by our certain Subsidiaries Park Medicity (NCR) and Blue Heavens, respectively. | 60.50 |
| 3 | Funding capital expenditure for purchase of medical equipment by the Company and our certain Subsidiaries, Blue Heavens and Ratangiri. | 27.46 |
| 4 | Unidentified inorganic acquisitions and general corporate purposes. | 245.32 |
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 2,320.93 | 2,133.70 | 1,912.10 | 1,592.82 |
| Total Income | 823.39 | 1,425.97 | 1,263.08 | 1,272.18 |
| Profit After Tax | 139.14 | 213.22 | 152.01 | 228.19 |
| EBITDA | 217.14 | 372.17 | 310.30 | 390.34 |
| NET Worth | 1,153.05 | 1,021.86 | 815.98 | 667.55 |
| Reserves and Surplus | 1,187.77 | 1,049.40 | 858.63 | 653.09 |
| Total Borrowing | 733.91 | 682.07 | 686.71 | 575.68 |
| Amount in ₹ Crore | ||||
| KPI | Mar 31, 2025 |
|---|---|
| ROE | 20.68% |
| ROCE | 17.47% |
| Debt / Equity | 0.61% |
| RoNW | 20.08% |
| PAT Margin | 15.30% |
| EBITDA Margin | 26.71% |
| Price to Book Value | 6.09 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (₹) | 5.55 | 6.44 |
| P/E (x) | 29.21 | 25.14 |
| Promoter Holding | 95.55% | 82.89% |
| Market Cap | ₹6997.28 Cr. | |
